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Background: Shoulder pain is the third most common reason for consultation with a physiotherapist and up to
26% of the general population might be expected to experience an episode at any one time. Disorders of the
shoulder muscles and tendons (rotator cuff) are thought to be the commonest cause of this pain. The long-term
outcome is frequently poor despite treatment. This means that many patients are exposed to more invasive
treatment, e.g. surgery, and/or long-term pain and disability.
Patients with this disorder typically receive a course of physiotherapy which might include a range of treatments.
Specifically the value of exercise against gravity or resistance (loaded exercise) in the treatment of tendon disorders
is promising but appears to be under-used. Loaded exercise in other areas of the body has been favourably
evaluated but further investigation is needed to evaluate the impact of these exercises in the shoulder and
particularly the role of home based or supervised exercise versus usual treatment requiring clinic attendance.
Methods/Design: A single-centre pragmatic unblinded parallel group randomised controlled trial will evaluate the
effectiveness of a self-managed loaded exercise programme versus usual clinic based physiotherapy. A total of 210
study participants with a primary complaint of shoulder pain suggestive of a rotator cuff disorder will be recruited
from NHS physiotherapy waiting lists and allocated to receive a programme of self-managed exercise or usual
physiotherapy using a process of block randomisation with sealed opaque envelopes. Baseline assessment for
shoulder pain, function and quality of life will be undertaken with the Shoulder Pain & Disability Index, the Patient
Specific Functional Scale and the SF-36. Follow-up evaluations will be completed at 3, 6 and 12 months by postal
questionnaire. Both interventions will be delivered by NHS Physiotherapist’s.
An economic analysis will be conducted from an NHS and Personal Social Services perspective to evaluate cost-
effectiveness and a qualitative investigation will be undertaken to develop greater understanding of the experience
of undertaking or prescribing exercise as a self-managed therapy.
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Shoulder pain is one of the most common musculoskel-
etal symptoms with prevalence estimated at between 16 to
26% in the general population at any one time [1,2]. It is
the third most common primary care musculoskeletal
presentation [3] and the third most common reason for
consultation with a physiotherapist [4]. Impaired shoulder
function impacts significantly upon activities of daily liv-
ing, including eating, dressing and working [5]. Disorders
of the shoulder muscles and tendons (rotator cuff) are the
commonest cause of this pain [6]. However long-term
outcome is frequently poor for a significant proportion of
patients which means that many are subsequently exposed
to more invasive and costly treatment options, e.g. injec-
tions, surgery, and/or long-term pain and disability [7].
Shoulder pain, incorporating rotator cuff disorders, is a
significant burden to the NHS and society. It has been
identified that around 1% of adults in the UK consult
their GP with a new presentation of shoulder pain each
year. This amounts to over 500,000 adults. Costs in the
first 6 months following primary care contact have been
estimated to be €690 which means that costs attributable
to this problem are in the region of €345 million or £310
million per year. Almost 50% of this cost is attributable
to sick leave from paid employment [8]. Additionally, in
2005/6, 16,885 patients were admitted to hospital diag-
nosed with problems relating to the rotator cuff [9].
NHS costs associated with surgical procedures for such
shoulder problems are estimated at £1,762 [10], which
equates to a conservative estimate of almost £30 million
per year. Clearly chronic rotator cuff disorders bring the
associated health costs and economic burden, including
loss of productivity, associated with other chronic condi-
tions [5]. Therefore, this is an important health and so-
cial care problem for patients, clinicians, commissioners
and researchers to consider.
Despite rotator cuff disorders being such a common
shoulder problem there is a lack of high quality studies
upon which to base practice [11]. Numerous systematic
reviews have been undertaken in relation to subacromial
impingement syndrome, an umbrella term encompassing
rotator cuff disorders, investigating the various plausible
interventions including physiotherapy, corticosteroid
injections and surgery but all identify the insufficiency of
the evidence base when attempting to draw conclusions
[12-17]. Specifically in relation to the rotator cuff, a re-
cent systematic review, which included 4 randomised
controlled trials, suggested that loaded exercise, i.e. exer-
cise against gravity or resistance, in the treatment of this
disorder was promising [18] but due to the paucity of re-
search and methodological limitations of the included
studies further research is warranted. It was also recog-
nised that home based or supervised exercise appears to
confer similar outcomes to interventions, includingtherapist-led interventions, which were offered in a
clinic-based setting. Additionally the benefits of loaded
exercise have been reported in a particularly resistant pa-
tient group with long standing shoulder pain awaiting
surgery due to a lack of response to previous conserva-
tive care [19]. Although small (n = 9), this uncontrolled
pilot study reported that 56% responded to the point
where they no longer required surgery despite a mean
duration of pain of 41 months. Chronic rotator cuff ten-
don disorders have been shown to demonstrate similar
pathological changes to tendon disorders in other areas
of the body, e.g. the elbow, Achilles tendon, patellar ten-
don [20] where favourable results including reduced pain
and improved function have been demonstrated in re-
sponse to similar loaded exercise [21].
A recent survey of current practice suggests that phy-
siotherapists usually offer a wide range of interventions
for rotator cuff disorders including advice, stretching, ex-
ercise, manual therapy, massage, strapping, acupuncture,
electrotherapy, corticosteroid injection [22]. The majority
of UK physiotherapists would expect patients to engage
with some level of self-management but more than 58%
would ask the patient to return for therapist-led inter-
ventions. The variability in the approach of physiothera-
pists might reflect the lack of high quality evidence upon
which practice can be based.
It is hypothesised that self-managed loaded exercise
has the capacity to reduce costs associated with rotator
cuff disorders and improve treatment outcome which
therefore reduces the need for work absenteeism and
further expensive invasive interventions. There is a clear
need for high quality research in this area to inform clin-
ical practice and commissioning priorities. At a time
when healthcare agendas are emphasising the need to
encourage the self-management of long-term conditions
this research would build upon the developmental work
that has been undertaken so far and, based upon high
quality research methods, will offer useful clinical and
cost data upon which practice can be developed and fu-
ture research can be based.
Methods/Design
Aims
The proposed study aims to answer the question: Is a
self-managed exercise programme more effective than
usual physiotherapy for chronic rotator cuff disorders?
The objectives are:
 To evaluate clinical effectiveness of loaded exercise
in terms of pain, function and well-being.
 To evaluate cost-effectiveness of the interventions.
 To investigate patient adherence with treatment.
 To explore the perceptions and experience of the
study participants.
Littlewood et al. BMC Musculoskeletal Disorders 2012, 13:62 Page 3 of 7
http://www.biomedcentral.com/1471-2474/13/62Methods
The study design is a single-centre pragmatic unblinded
parallel group randomised controlled trial (RCT) com-
bined with qualitative investigation of patient and ther-
apist experience. The study will be based at Doncaster &
Bassetlaw Hospitals NHS Foundation Trust, UK.
The first part of the proposed study will be a RCT
comparing self-managed loaded exercise versus usual
physiotherapy.The intervention
The intervention is self-managed loaded (against gravity
or resistance) exercise. The exercise, prescribed by the
physiotherapist but completed by the patient independ-
ently, involves exercising the affected shoulder against
gravity, a resistive therapeutic band or hand weight over
3 sets of 10 to 15 repetitions completed twice per day.
This exercise can be uncomfortable for the patient but is
prescribed to ensure that the discomfort is manageable.
Exercise prescription is guided by symptomatic response
requiring that pain is produced during exercise that
remains no worse upon cessation of that exercise [7,23].
Hence participants with more severe symptoms tend to
commence a lighter regime to begin with. A typical
programme is presented in Box 1.
To maintain the pragmatic value of the study, in both
arms of the trial, the treating physiotherapists will deter-
mine the number of sessions, frequency and point of treat-
ment cessation. However, the emphasis of the intervention
arm is towards self-management with supervision and
guidance only offered by the physiotherapist [7,23].The comparator
Usual physiotherapy might include a range of interven-
tions including advice, stretching, exercise, manual ther-
apy, massage, strapping, acupuncture, electrotherapy,
corticosteroid injection at the discretion of the treating
physiotherapist.
Prior to the recruitment of patients into the trial, the
physiotherapists of Doncaster & Bassetlaw Hospitals
NHS Foundation Trust who usually treat patients withBox 1 Typical loaded exercise progression
1. Week 0: Baseline assessment:
•Resisted isometric (no movement) shoulder abduction (taking the arm out
•Resisted shoulder abduction from 0 to 30° using moderate resistance from
2. Week 3: Initial follow-up:
•Resisted shoulder abduction from 80 to 120° using light weight, e.g. tin of
3. Week 6: Second follow-up:
•Resisted shoulder abduction from 80 to 120° with progressively increasing
4. Week 12: Final follow-up/discharge.rotator cuff disorders will be invited to participate in the
study. A participant information sheet will be provided
and explained via an initial information session delivered
by the research team. If they wish to be included they
will be asked to complete a consent form and return to
the chief investigator within 2 weeks. During these train-
ing sessions the issue of contamination of the control
arm and the implications will be discussed in an attempt
to minimise contamination. The degree of any contamin-
ation will be evaluated via review of patient records and
reported accordingly.Recruitment
Inclusion criteria will be: (i) Age> 18 years, (ii) Willing
and able to participate, (iii) Primary complaint of shoulder
pain with or without referral into the upper limb for> 3
months, (iv) No/minimal resting shoulder pain, (v) Range
of shoulder movement largely preserved, and (vi) Shoulder
pain provoked consistently with resisted muscle tests, usu-
ally abduction or lateral rotation.
Exclusion criteria will be: (i) Shoulder surgery within
last 6 months, (ii) Reasons to suspect systemic pathology
including inflammatory disorders, (iii) Cervical repeated
movement testing affects shoulder pain and/or range of
movement. People who are unable to understand written
and spoken English will be included in the study and
NHS translation services will be accessed to accommo-
date their needs.
Potential trial participants will be identified from the
NHS physiotherapy waiting list by a physiotherapist who
usually has access to this information as part of their
clinical role. Initial contact will be made through an
introductory letter. Along with this letter the potential
participants will also receive a participant information
sheet and consent form. The letter will be followed up
with a telephone call made by the physiotherapist one
week later where further study information will be
relayed as required and an enquiry about further partici-
pant involvement will be made. If the call recipient
expresses interest in participating in the study the
physiotherapist will then undertake initial telephoneto the side) against a wall, or
Theraband (resistive band used for training purposes).
food.
repetition and weight, e.g. heavy Theraband or dumbbell.
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teria i to ii. If these criteria are met then the potential
participant will be invited to read the participant infor-
mation sheet, ask any questions and sign the consent
form prior to attending for physical examination screen-
ing for inclusion criteria v to vi and exclusion criteria iii.
If the participant does not wish to pursue the discussion
or does not meet the criteria they will be thanked for
their time and told that their referral will continue to be
treated as per usual arrangements.
Physical examination screening will also be carried out
by an experienced clinical physiotherapist. The physical
examination screening will take up to 30 minutes and
will include assessment of neck and shoulder movements
and any associated symptomatic responses as per a typ-
ical musculoskeletal examination. If potential partici-
pants do not meet inclusion criteria v to vi they will be
thanked for their time, offered advice about their pre-
senting problem in line with the physical examination
screening, e.g. advice to keep the arm moving, offered a
generic advice leaflet produced by the Physiotherapy de-
partment at the Doncaster & Bassetlaw Hospitals NHS
Foundation Trust and told that their referral will con-
tinue to be treated as per usual arrangements. This re-
search study will not interfere with the timing of
receiving physiotherapy. The process of including or ex-
cluding participants will take place whilst the referral
remains on the waiting list.
Informed consent
Prior to attending the physical examination screening a
participant information sheet and consent form will be
provided by post. The physiotherapist will offer an over-
view of the information sheet and answer any questions
at the time of the initial telephone call. The potential
participants will then be offered an appointment for a
physical examination screening or, if more time is
needed, will be offered a follow-up telephone call within
the proceeding 2 weeks. If the participant does not wish
to be considered for the study they will be thanked for
their time and told that their referral will continue to be
treated as per usual arrangements.
The potential participants will provide a signed con-
sent form prior to the physical examination screening
tests. Where consent is gained, the participants General
Practitioner will also be informed of their inclusion in
the study by letter. All potential participants who meet
the criteria following physical examination screening will
be eligible to be randomised. Those participants who do
not meet the criteria will not be eligible to be rando-
mised and will be informed of this along with the rea-
sons. We expect only a small minority to be excluded at
this stage and this aspect of the process is made clear in
the information sheet.Baseline/outcome assessment
After the participants have been assessed for eligibility
and consent has been gained, prior to randomisation,
they will complete a range of appropriate patient-
reported outcome measures to establish baseline pain,
function, quality of life and level of self-efficacy. Add-
itionally, the participants’ preference for one treatment
or the other, if they had a free choice, will be noted to
enable analysis of the effect of preference on outcome.
The primary aim of the proposed study is to evaluate the
clinical and cost-effectiveness of self-managed loaded exer-
cise versus usual physiotherapy for rotator cuff disorders.
The primary outcome measure will be the Shoulder Pain
& Disability Index (SPADI) [24] score at 12 weeks. SPADI
is a self-report measure specifically developed to evaluate
pain and function in patients with shoulder pathology [25].
It is a commonly used measure which has been validated
for use in this patient population and a minimally clinically
important change of 10 points has been identified [25].
The SPADI includes 13 items divided into 2 sub-scales;
pain (5 items), disability (8 items). The responses are indi-
cated on a visual analogue scale where 0=no pain/no diffi-
culty and 10=worst imaginable pain/so difficult it requires
help. The items are summed and converted to a total score
out of 100.
The Short-form 36 (SF-36) is a generic measure of health
related quality of life [26] and is the most widely used
measure of this nature. The SPADI & SF-36 will be
repeated at 12, 24 and 52 weeks and returned by post.
These measures will be complemented by the patient spe-
cific functional scale (PSFS) which is a patient-specific out-
come measure which investigates functional status and
is intended to complement the findings of generic or
condition-specific measures [27]. The PSFS has been
shown to be valid and responsive in various musculo-
skeletal populations [28]. Due to the nature of the PSFS,
this measure will be completed at baseline and then
completed, until the end of the treatment episode, in the
presence of the attending physiotherapist. Treatment dur-
ation is likely to be in the region of 3 months with the
PSFS being completed at 1, 2 and 3 months post baseline.
We are interested in evaluating levels of adherence
with treatment but also exploring possible factors that
might predict non-adherence in this context. A range of
such factors have been identified including level of pain
at baseline, levels of physical functioning, levels of well-
being [29], all of which can be captured with the afore-
mentioned measures. However, levels of self-efficacy ap-
pear to be an important determinant of adherence [29]
and so this will be captured via the General Self-efficacy
scale (GSES) [30] at baseline. The GSES is a 10-item
measure that has been developed to measure this con-
struct and has been validated across different popula-
tions in different countries [31].
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measures including range of movement and strength
[32] these measures will not be undertaken as part of
this study. In the absence of objectives measures of ad-
herence, levels of treatment adherence will be formally
measured through the use of an exercise diary including
number and percentage of treatment sessions attended
and percentage of exercises completed as reported by the
patient.
Randomisation
Block randomisation will be carried out by an adminis-
trator based in the physiotherapy department but inde-
pendent to the study. Following receipt of written
informed consent and baseline assessment, a computer
generated random number sequence indicating group al-
location will be concealed in sealed opaque envelopes
which will be consecutively numbered. The group alloca-
tion and baseline PSFS assessment will be attached to
the patient referral for the attention of the treating
physiotherapist in readiness for the programme of
treatment.
Sample size calculation
The sample size calculation is based upon the primary
outcome measure, the SPADI, where a 10-point change
is regarded as a minimally clinically important change in
shoulder function [24]. Assuming a standard deviation of
24 points, a power of 80% and a (two-sided) significance
level of 5%, 91 participants per group will be required.
We will allow for a 15% loss to follow-up and aim to re-
cruit 105 participants per group. Data from the Physio-
therapy department at Doncaster & Bassetlaw Hospitals
NHS Foundation Trust indicates that 70 potentially suit-
able patients are referred for treatment each month.
Hence a recruitment rate of 17 to 18 per month is felt to
be realistic and manageable in the allotted timescale.
Data analysis
As the trial is a pragmatic parallel group RCT data will
be reported and presented according to the revised
CONSORT statement and statistical analyses will be per-
formed on an intention-to-treat basis. All statistical ex-
ploratory tests will be two-tailed with α= 0.05. Baseline
demographic and health-related quality of life data (SF-
36) will be assessed for comparability between the treat-
ment groups. The primary aim is to compare the effect
of loaded exercise versus usual physiotherapy. The mean
SPADI total score at 12 weeks follow-up is the primary
efficacy response variable. A two independent samples t-
test will be used to compare mean SPADI total scores
between the groups (loaded exercise and usual physio-
therapy groups). In the event of differences between the
groups with respect to baseline measurements, multipleregression or analysis of covariance (ANCOVA) will be
used to adjust the treatment effect for these variables.
Secondary outcomes will be analysed in a similar way.
For the repeated PSFS assessments at baseline and ter-
mination of treatment and (SPADI, SF-36) assessments
at baseline, 12, 24 and 52 weeks a summary measure
such as the Area Under the Curve (AUC) will be calcu-
lated for each patient. A two independent samples t-test
will be used to compare mean AUC between the groups
(loaded exercise and usual physiotherapy groups).
Economic analysis
A cost-utility analysis will be undertaken using a NHS
and Personal Social Services (PSS) perspective. The
health outcomes will be expressed in terms of quality
adjusted life years (QALYs). The QALY combines length
and quality of life into a single index number between 0
and 1 where 0 corresponds to a health state judged to be
equivalent to death and 1 corresponds to optimal health.
The SF-6D will be used to calculate QALYs. The SF-6D
is composed of six multi-level dimensions which
describes 18,000 health states in all. The SF-6D will be
derived from a selection of SF-36 items which will be
completed at baseline and follow-up visits during the
trial. Any patient who completes the SF-36 can be
uniquely classified according to the SF-6D.
Data regarding resource utilisation will be collected via
patient notes and patient questionnaire returned at 3, 6
and 12 months along with the other measures of clinical
outcome. A range of costs will be considered including
the number of physiotherapy sessions attended, medica-
tions (including steroid injections) and referrals to sur-
gery (with associated follow-up). These and other unit
costs will be taken from the most recent National Refer-
ence Costs, British National Formulary and PSSRU pub-
lication ‘Unit costs of health and social care’. This will
enable an estimation of the total cost for each participant
as well as the average total cost for each treatment
group.
As with the clinical outcomes, economic analysis will
be on an intention-to-treat basis. The between groups
differences will be compared using 2-independent sam-
ples t-tests. The QALY value will be estimated using
straight line interpolation between data points. So, for
example, if a patient reports quality of life (QoL) equal
to 1 at each time point during the trial this will equate to
a QALY of 1 and if they report QoL equal to 0.5 at each
time point during the trial this will equate to a QALY of
0.5. Mean incremental costs and QALYs will be com-
bined into an incremental cost effectiveness ratio (ICER)
to enable assessment of the relative cost-utility. Sampling
uncertainty will be represented by plots on the cost-
effectiveness plane and associated cost-effectiveness ac-
ceptability curves (CEACs). To reflect uncertainty and to
Littlewood et al. BMC Musculoskeletal Disorders 2012, 13:62 Page 6 of 7
http://www.biomedcentral.com/1471-2474/13/62enable valid inferences to be made, any missing data will
be imputed using multiple imputation. This process will
enable a decision about the acceptability of the interven-
tion in terms of an effective use of NHS resources.
The qualitative investigation
The primary objective of the qualitative investigation is
to explore perceptions and experience of the study parti-
cipants. The intervention is largely self-managed and can
be uncomfortable for patients which is in contrast to the
majority view of usual physiotherapy [22]. Hence this as-
pect of the study is important to provide complementary
data to the findings of the RCT because these factors
might serve as barriers to successful outcome and/or real
world implementation.
Recruitment
Participants for the qualitative aspect of the study will
be purposively selected from the treating physiothera-
pists and those patients recruited to the intervention
arm of the RCT. All patient participants randomised to
the intervention arm of the RCT will be eligible to enter
and will be selected to gain a balanced sample of male/
female and treatment adherers/non-adherers. All thera-
pists involved in the delivery of the intervention will be
eligible to enter.
Information relating to this aspect of the study will be
included in the initial participant information sheet. The
chief investigator (CL) will identify potential patient par-
ticipants from the data generated by the RCT and will
initially contact them by telephone to discuss whether
they would be able to discuss their experiences. If their
response is favourable then a separate consent form will
be posted to them and completed prior to being invited
to attend an individual interview at their convenience.
The interviews may be conducted at the patients’ home
or physiotherapy department.
The eligible physiotherapists will be approached as a
group during the regular training sessions held through-
out the duration of the trial, led by the chief investigator,
and an open letter including a participant information
sheet and consent form will invite them to contact CL
with a view to discussing participation in this aspect of
the study. If the physiotherapist wishes to participate
then a mutually convenient individual interview at the
physiotherapy department will be scheduled.
It is expected that interviews will last between 30 to 60
minutes. Purposive sampling will continue until data sat-
uration. Data saturation is the point where on-going ana-
lysis reveals no new themes emerging from the data but
it is estimated that 10 to 20 patient interviews will be
required and up to 10 therapist interviews. Once it is
thought that data saturation has been attained, 2 more
interviews will be conducted to confirm this.Data collection
Interviews will be directed by topic guides These discus-
sions will be recorded using a digital voice recorder and
subsequently transcribed verbatim.
Data analysis
CL and SM will analyse the data using the framework
approach.
The framework approach has been developed specific-
ally for applied research in which the objectives of the
investigation are set a priori [33]. The 5 stages of data
analysis associated with the framework approach are as
follows:
1. Familiarisation – identifying key ideas and themes
2. Identifying a thematic framework – identifying all
key issues, concepts and themes by which the data
can be examined
3. Indexing – application of the thematic framework to
all the data
4. Charting – Organisation of the data according to the
defined thematic framework to which they relate to
form common charts
5. Mapping and Interpretation – using the charts to
define concepts, map the range and nature of
phenomena, create typologies and find associations
with a view to providing explanations for the findings.
One clear advantage of the framework method is the
systematic and visible stages of the analysis process
[34,35]. The patients and physiotherapists involved will
be invited to inspect the outcomes of the analysis in an
attempt to maximise validity of the interpretations.
Patient & public involvement
A formal patient and public involvement event was held
with the aim of seeking lay opinion regarding the design
and conduct of the SELF study. A focus group led by CL
and JA was undertaken with a sample of volunteers cur-
rently attending for physiotherapy at Doncaster & Bassetlaw
Hospitals NHS Foundation Trust. In summary, the lay
group found our initial proposals acceptable but suggested
that initial approach by letter, a full description of the con-
tent of the treatment arms, an enhanced exercise diary
incorporating a visual illustration of any prescribed exercise
and encouragement to the physiotherapists involved to help
set specific treatment goals might improve the design and
conduct of the SELF study. These features have been incor-
porated into this current version of the protocol.
Ethical approval
The protocol was approved by the National Research Ethics
Service Committee Yorkshire & the Humber – Leeds West,
UK on the 6th January 2012.
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